We use privacy-friendly analytics. Read our privacy policy.

Herb Profile

Kava

Piper methysticum

Kava is best framed for short term anxiety and relaxation research tied to kavalactone preparations, with safety screening for liver disease, alcohol use, sedatives, hepatotoxic medications, pregnancy, and prolonged daily use.

Last reviewed: •3 sources citedReport a correctionProfile-wide ·B Moderate

Use extra caution — hepatotoxicity risk Details

Evidence
Moderate Evidence
Typical onset
Varies by prep
Safety rating
Moderate caution
Best for
Sleep, Stress, Cognitive function
Avoid / review if
Alcohol, Hepatotoxic Drugs
Kava monograph visual
The Hippie Scientist illustration
Verdict: KavaSituation-dependent

Bottom line

Genuinely effective for acute anxiety, but liver-safety concerns make it a short-term, carefully-sourced choice rather than a daily habit.
Evidence confidence
Moderate for anxiety — but the safety profile drives the verdict
Expected onset
30–60 minutes
Give it
Short-term, occasional use only

Safety: Rare but serious liver injury is reported. Avoid with alcohol, other sedatives, or existing liver conditions; involve a clinician.

On the evidence: Meta-analyses support short-term anxiolytic effects; safety signals limit routine use.

Best for

  • Short-term situational anxiety
  • Acute tension when non-sedating options fall short

Not ideal for

  • Daily long-term use
  • Anyone with liver concerns or on hepatotoxic medications
  • Combining with alcohol or sedatives

Consider instead: L-theanine — for lower-risk everyday calm

Permanent link to this scientific verdict
How strong is the evidence?Moderate

Why not higher

  • Rare but serious liver-injury reports shape the risk picture
  • Long-term daily-use safety data is limited
  • Product quality (cultivar, extraction) varies widely

Why not lower

  • Multiple randomized trials and meta-analyses show a real anxiolytic effect
  • Short-term effects are relatively fast and consistent
  • Water-extracted noble cultivars have a better-understood safety profile

Practical takeaway: For occasional, short-term situational anxiety with a carefully sourced product — not a daily habit. Avoid with alcohol, sedatives, or existing liver concerns, and involve a clinician.

Next steps

Start here

New to this? Begin with Anxiolytics beyond ashwagandha.

Compare first

Continue reading

Safety

Safety & Cautions

hepatotoxicity risk

Elevated caution

Caution level: Elevated. One caution category applies — read it before use.

  • Liver-SensitiveLiver-related caution language appears in the profile.
Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Alcohol
  • Hepatotoxic Drugs

Safety classifications

  • Liver-Sensitive: Liver-related caution language appears in the profile.

Full safety note

  • hepatotoxicity risk

Safety labels

  • Liver-Sensitive

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

Moderate Caution

68 flagged pairings

Sedation / CNS depression

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Sedation / CNS depressionCertainty: Theoretical

Data provenance recorded for 68 of 68 pairings in this mechanism group.

+56 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Evidence

Evidence Summary

Evidence lens

Useful signal, but study design, dose, and population still matter.

ModerateModerate Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Neurotransmitter Modulation · Stress Response Modulation

Research maturity: Established research — Long Term Human Evidence May Be Limited.

Safety boundary: Safety note available — hepatotoxicity risk

This profile cites 3 human studies.

Study design details
Evidence Grade

Grade B: Moderate Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Meta-analysis
Risk of Bias
Low
Consistency
Not assessed
Strongest recorded design is a meta-analysis, drawn from 3 recorded studies, 1 in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (3)1 human evidence source · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 3 of 3 studies.

What the evidence actually shows

This table contains 3 structured sources, including 1 human evidence source; 0 are human trials.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce

Sarris J et al. · World J Biol Psychiatry · 2022

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

——————PubMed →

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options

Garakani A et al. · Front Psychiatry · 2020

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

——————PubMed →

Common Herbal Dietary Supplement-Drug Interactions

Asher GN et al. · Am Fam Physician · 2017

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

——————PubMed →

Dosing & Timing

Dose guidance
60 250 mg/day kavalactones
How Kava works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Kava Works

How Kava WorksKava acts on biological target pathways via neurotransmitter (modulation), leading to sleep quality.KavaBiological TargetBiological pathwayNeurotransmitterModulationSleep Quality ↑Onset + depthHPA AxisModulation
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
  • Neurotransmitter Modulation
  • Stress Response Modulation

Active Compounds

Key constituents studied in Kava, with full pharmacology and safety profiles.

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Kava

Goal guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Sourcing options disabled for safety

Direct product recommendations and affiliate links are suppressed for this herb due to its high caution or needs-review safety classification.

Evaluate the safety checks, contraindications, and potential medication interactions above under clinician supervision before use.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Suggest an ingredient, comparison, or study →

Free safety checklist

Get the Kava research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

← Back to herbs librarySafety checker →